<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Cancer Genomics & Multi-Omics Analysis – Project Details</title>
  <link rel="stylesheet" href="style.css" />
</head>
<body>
  <header class="site-header">
    <header class="topbar">
    <a class="back-btn" href="../index.html" aria-label="Back to portfolio">←</a>
    <a class="brand" href="../index.html">Monesha Basker</a>
    <nav class="nav" aria-label="Primary">
      <a class="nav-link active" href="../index.html">Projects</a>
      <a class="nav-link" href="../about.html">About Me</a>
      <a class="nav-link" href="../work.html">Work</a>
      <a class="nav-link" href="../contact.html">Contact</a>
    </nav>
  </header>

    <h1>Cancer Genomics & Multi-Omics Analysis</h1>
    <p class="subtitle">Data Analyst and Pipeline Developer | R, DESeq2, ggplot2, TCGA datasets</p>
  </header>

  <main class="container">
    <section class="project-details">
      <h2>Overview</h2>
      <p>
        I developed an R pipeline to study the relationship between genetic mutations and survival in kidney cancer patients using The Cancer Genome Atlas (TCGA). 
        This work combined both <strong>multi-omics patient matching</strong> across datasets and <strong>downstream genomic analysis</strong> including clustering, survival modeling, and pathway enrichment.
      </p>

      <h2>Tools</h2>
      <ul>
        <li>R and tidyverse</li>
        <li>DESeq2 for RNA-seq expression analysis</li>
        <li>ggplot2 for visualizations</li>
        <li>survival and survminer for Kaplan–Meier models</li>
        <li>TCGA ccRCC datasets, cBioPortal</li>
      </ul>

      <h2>Role</h2>
      <p>Data Analyst and Pipeline Developer</p>

      <h2>Description</h2>
      <p>
        The first step was ensuring consistency across omics data. I wrote R scripts to parse TCGA barcodes, standardize patient identifiers, 
        and remove duplicates. This alignment produced a clean core cohort of 354 patients with complete clinical, mutation, and RNA-seq coverage, 
        enabling downstream analysis without missing or misaligned data.
      </p>
      <p>
        Using this matched cohort, I clustered patients based on binary mutation profiles across the 50 most frequently altered genes, applying Ward.D2 hierarchical clustering. 
        Kaplan–Meier survival analysis compared outcomes between clusters, while Principal Component Analysis (PCA) confirmed the existence of distinct subgroups. 
        I then used DESeq2 for differential expression analysis and performed pathway enrichment to identify disrupted biological processes such as metabolism and immune signaling.
      </p>
      <p>
        I generated survival curves, mutation heatmaps, and pathway plots with ggplot2, making the pipeline modular and reproducible. 
        This project strengthened my ability to integrate data wrangling, unsupervised clustering, and survival modeling, and to connect genomic features to clinical outcomes.
      </p>
    </section>
  </main>

  <footer class="site-footer">
    <p>© 2025 Monesha Basker</p>
  </footer>
</body>
</html>
